(Q40595860)

English

Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 years

scientific article published on January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 years (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

meningococcal disease

1 reference

based on heuristic

inferred from title

author name string

Carol Rancourt

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jean-Pierre Grégoire

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

W Simons

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alain Dostie

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

429-442

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200321060-00006

0 references

Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meningococcal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The societal costs of severe to profound hearing loss in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost analysis of dialysis treatments for end-stage renal disease (ESRD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meningococcal vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rehabilitation of below-knee amputees: factors influencing outcome and costs in three programmes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis and pathophysiology of bacterial meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UK introduces new meningitis C vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12678569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200321060-00006

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

release_rnhw7fa2mng3jdtehre44xhhhy

1 reference

https://api.fatcat.wiki/v0/release/rnhw7fa2mng3jdtehre44xhhhy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40595860&oldid=1903500713"